# Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

> **NCT04636775** · — · UNKNOWN · sponsor: **Jun Zhang, MD, PhD** · enrollment: 46 (estimated)

## Conditions studied

- NSCLC Stage IV
- NSCLC, Recurrent

## Interventions

- **DIAGNOSTIC_TEST:** Microbiome

## Key facts

- **NCT ID:** NCT04636775
- **Lead sponsor:** Jun Zhang, MD, PhD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-29
- **Primary completion:** 2024-08-30
- **Final completion:** 2024-12-31
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04636775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04636775, "Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04636775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*